← Browse by Condition
Medical Condition

biliary tract neoplasms

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2

ClinicalMetric aggregates all active clinical trials for biliary tract neoplasms from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT04956640 Phase 1, Phase 2
Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Enrollment
540 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
View Trial →